Acura Pharmaceuticals, Inc. (OTCPK: ACUR)
Health Care · Pharmaceuticals · US
$0.00
-50.00% today · -66.8% 1Y
Acura Pharmaceuticals, Inc. (OTCPK: ACUR) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $6.67K and employs 9 people.
Over the last twelve months the share price has lost 66.8%, trading between 0.00 and 0.01.
Tweenvest scores Acura Pharmaceuticals, Inc. across four factors: quality 19/100, value 45/100, growth 0/100. Its strongest factor is value.
ACUR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $6.67K
- Revenue (TTM)
- $1.56M
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- 52.45
- 52-week high
- $0.01
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 66.65M
- Employees
- 9
- Next earnings
- —
About Acura Pharmaceuticals, Inc.
Acura Pharmaceuticals, Inc. operates as a drug delivery innovator, dedicated to exploring, developing, and bringing to market novel technologies and products aimed at enhancing medication safety across the United States. Its product portfolio features Oxaydo tablets, a potent Schedule II narcotic prescribed for managing both acute and chronic moderate-to-severe pain. The company also offers the Nexafed line, consisting of pseudoephedrine and acetaminophen tablets, widely utilized as nasal decongestants in a range of over-the-counter and prescription formulations for cold, sinus, and allergy relief. Beyond its current offerings, Acura is actively advancing six additional opioid products through various stages of formulation development. To support its global reach, Acura Pharmaceuticals maintains strategic collaboration and licensing agreements with Egalet US, Inc. and Egalet Ltd. for the worldwide production and commercialization of its Oxaydo products. Furthermore, it has established a development and commercialization partnership with Abuse Deterrent Pharma, LLC to create LTX-03, an immediate-release tablet leveraging the proprietary LIMITx technology. Established in 1935, the company's operations are headquartered in Palatine, Illinois.
- ISIN
- US00509L8028
- Founded
- 1935
- Listed since
- Mar 28, 1986
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.